NEW YORK LIFE INVESTMENT MANAGEMENT LLCNEW YORK LIFE INVESTMENT MANAGEMENT LLC

Institutional investor · Portfolio as of Q3 2022

SEC EDGAR SourceSEC Filings

Top Holdings1,202 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

APPLE INC

2.4M$330M4.0%$133.91+1.22%
2 qtrssince 2022-Q2
Decreased
0
IQSUIQSU
ETF

NEW YORK LIFE INVESTMENTS ET

9.6M$293.4M3.5%$29.06+3.01%
10 qtrssince 2020-Q2
Decreased
0

MICROSOFT CORP

1.2M$274.8M3.3%$252.93-8.55%
2 qtrssince 2022-Q2
Decreased
0
CLRGCLRGDelisted
ETF

IQ U.S. Large Cap ETF

9M$254.6M3.1%$21.96+28.88%
15 qtrssince 2019-Q1
Decreased
0
CSMLCSMLDelisted
ETF

IQ U.S. Small Cap ETF

6.2M$178.3M2.2%$26.03+8.87%
15 qtrssince 2019-Q1
Increased
58
CPLBCPLB
ETF

NEW YORK LIFE INVTS ACTIVE E

8.6M$177.9M2.2%$18.39-5.70%
3 qtrssince 2022-Q1
Increased
56
IQINIQINDelisted
ETF

NYLI 500 International ETF

6.7M$161.2M1.9%$19.67+14.59%
15 qtrssince 2019-Q1
Increased
51
IQSIIQSI
ETF

NEW YORK LIFE INVESTMENTS ET

7.6M$160.5M1.9%$21.87-11.75%
10 qtrssince 2020-Q2
Increased
51

AMAZON.COM INC

1.4M$158M1.9%$108.97+5.35%
2 qtrssince 2022-Q2
Increased
48
VCSHVCSH
ETF

VANGUARD S/T CORP BOND ETF

1.5M$114.6M1.4%$66.73-1.78%
2 qtrssince 2022-Q2
Decreased
0
HFXIHFXI
ETF

NYLI FTSE INTERNATIONAL EQUITY CURRENCY NEUTRAL ETF

5.8M$110.8M1.3%$15.69+9.51%
15 qtrssince 2019-Q1
Increased
48

TESLA INC

417,575$110.8M1.3%$255.58+4.94%
2 qtrssince 2022-Q2
Increased
76

ALPHABET INC-CL A

973,245$93.1M1.1%$97.40-0.73%
2 qtrssince 2022-Q2
Increased
76

ALPHABET INC-CL C

842,131$81M1.0%$98.08-0.73%
2 qtrssince 2022-Q2
Increased
68

UNITEDHEALTH GROUP INC

139,086$70.2M0.8%$485.18-1.02%
2 qtrssince 2022-Q2
Decreased
0
CWBCWB
Convertible

SPDR BLOOMBERG CONVERTIBLE S

1.1M$69.1M0.8%$59.48-1.54%
2 qtrssince 2022-Q2
Decreased
0
SRLNSRLN
ETF

SSGA ACTIVE ETF TR

1.7M$68.7M0.8%$31.37-0.89%
2 qtrssince 2022-Q2
Decreased
0

BERKSHIRE HATHAWAY INC-CL B

253,672$67.7M0.8%$273.49-1.43%
2 qtrssince 2022-Q2
Increased
42

EXXON MOBIL CORP

712,430$62.2M0.8%$77.67+1.48%
2 qtrssince 2022-Q2
Increased
45

JOHNSON & JOHNSON

375,138$61.3M0.7%$159.42-6.40%
2 qtrssince 2022-Q2
Increased
41
$8.3B
AUM
1,202
Positions
Q3 2022
Filing
Rating · 3.5
Quarterly Portfolio Change
+4%Q2'21$1.7B+5%Q3'21$1.8B+6%Q4'21$1.9B-1%Q1'22$1.9B+355%Q2'22$8.6B-4%Q3'22$8.3B
Activity profile
$ moved · Q3'22
New16%Increased27%Decreased45%Exited11%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.3 quarters
<1Q3%1-4Q92%1-2Y1%2Y+3%

NEW YORK LIFE INVESTMENT MANAGEMENT LLC manages $8.3B across 1202 positions as of Q3 2022. Top holdings: AAPL (4.0%), IQSU (3.5%), MSFT (3.3%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q3 2022 Summary

Active quarter - 42 new positions, 90 exits, 725 increased. Top move: TSLA (INCREASED, conviction 76). Portfolio: $8.3B across 1202 positions.

Top holdings by portfolio weight

Total AUM$8B
AAPL3.99%
IQSU3.55%
MSFT3.32%
CLRG3.08%
CSML2.16%
CPLB2.15%
IQIN1.95%
IQSI1.94%
AMZN1.91%
VCSH1.39%
Other1.34%

Portfolio allocation by GICS sector

Sectors11
Unknown38.08%
Technology15.00%
Healthcare9.38%
Financial Services8.23%
Consumer Cyclical7.16%
Industrials5.00%
Communication Services4.71%
Consumer Defensive4.48%
Energy2.74%
Real Estate2.03%
Other3.19%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Technology
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record81
Conviction40
Concentration43
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
USHYUSHYISHARES BROAD USD HIGH YIELD
Q3 2024 Q2 2026+906,416 shares+$33.7M
7Q
APHAPHAMPHENOL CORP-CL A
Q4 2024 Q2 2026+10,995 shares+$19.8M
7Q
ATOATOATMOS ENERGY CORP
Q4 2024 Q2 2026+2,574 shares+$1.1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used